Results 231 to 240 of about 11,371 (259)
Some of the next articles are maybe not open access.
Expert Opinion on Pharmacotherapy, 2000
Cabergoline (CAB) (1-[(6-allelylergolin-8 beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethyl-urea) is an ergoline derivative with potent, selective and long-lasting inhibitory activity on prolactin (PRL) secretion acting on dopamine receptors present in pituitary lactotrophes.
COLAO, ANNAMARIA +2 more
openaire +3 more sources
Cabergoline (CAB) (1-[(6-allelylergolin-8 beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethyl-urea) is an ergoline derivative with potent, selective and long-lasting inhibitory activity on prolactin (PRL) secretion acting on dopamine receptors present in pituitary lactotrophes.
COLAO, ANNAMARIA +2 more
openaire +3 more sources
Pituitary, 2016
Acromegaly, a rare disease due to growth hormone (GH) hypersecretion by a pituitary adenoma, is associated with severe comorbidity and premature death if not adequately treated. The usual first-line treatment is surgery. Various drugs, including somatostatin receptor ligands, dopamine agonists and GH receptor antagonists, are now available for use if ...
Emmanuelle Kuhn, Philippe Chanson
openaire +3 more sources
Acromegaly, a rare disease due to growth hormone (GH) hypersecretion by a pituitary adenoma, is associated with severe comorbidity and premature death if not adequately treated. The usual first-line treatment is surgery. Various drugs, including somatostatin receptor ligands, dopamine agonists and GH receptor antagonists, are now available for use if ...
Emmanuelle Kuhn, Philippe Chanson
openaire +3 more sources
Prolactinomas, cabergoline, and pregnancy
Endocrine, 2014Hyperprolactinemia, frequently caused by a prolactinoma, is an important cause of infertility among young women. Dopamine agonists (DA) are the treatment of choice. Although cabergoline (CAB) is currently considered the gold standard DA, bromocriptine (BRC) remains the drug of choice for women desiring pregnancy, as it was proven to be safe in more ...
Andrea Glezer, Marcello D. Bronstein
openaire +3 more sources
Neuro-Ophthalmology, 1999
Cabergoline is a potent, D2-selective new dopamine agonist with a half-life of 65 hours. We report two cases and review the literature on cabergoline in prolactinomas. Cabergoline appears to be more effective and better tolerated than bromocriptine, compliance may be improved, and costs are comparable.
Anna B. Fierz +4 more
openaire +2 more sources
Cabergoline is a potent, D2-selective new dopamine agonist with a half-life of 65 hours. We report two cases and review the literature on cabergoline in prolactinomas. Cabergoline appears to be more effective and better tolerated than bromocriptine, compliance may be improved, and costs are comparable.
Anna B. Fierz +4 more
openaire +2 more sources
Clinical Pharmacokinetics of Cabergoline
Clinical Pharmacokinetics, 2003Cabergoline is a synthetic ergoline dopamine agonist with a high affinity for D(2) receptors indicated for use in both early and advanced Parkinson's disease and in hyperprolactinaemic disorders. Following oral administration, peak plasma concentrations of cabergoline are reached within 2-3 hours.
Del Dotto P, BONUCCELLI, UBALDO
openaire +4 more sources
Effect of Cabergoline on Metabolism in Prolactinomas
Neuroendocrinology, 2013<b><i>Introduction:</i></b> Hyperprolactinemia has been implicated in the pathogenesis of obesity and glucose intolerance and is reportedly associated with an impaired metabolic profile. The current study aimed at investigating the effects of 12- and 60-month treatment with cabergoline (CAB) on metabolic syndrome (MetS) in ...
AURIEMMA, RENATA SIMONA +12 more
openaire +4 more sources
DNP - Der Neurologe & Psychiater, 2019
Ein bis dahin psychiatrisch unauffalliger Landmaschinenmechaniker mit Restless-Legs-Syndrom entwickelte unter der Behandlung mit Cabergolin eine Spielsucht, haufte massiv Schulden an und beging einen Suizidversuch. Nach Absetzen des Dopaminagonisten: restitutio ad integrum.
Thomas Nissen, Andreas Broocks
openaire +2 more sources
Ein bis dahin psychiatrisch unauffalliger Landmaschinenmechaniker mit Restless-Legs-Syndrom entwickelte unter der Behandlung mit Cabergolin eine Spielsucht, haufte massiv Schulden an und beging einen Suizidversuch. Nach Absetzen des Dopaminagonisten: restitutio ad integrum.
Thomas Nissen, Andreas Broocks
openaire +2 more sources
Cabergoline-Associated Erythema Nodosum
Annals of Pharmacotherapy, 2008Objective: To report a case of erythema nodosum (EN) and related inflammatory arthropathy in a patient on cabergoline therapy for a microprolactinoma. Case Summary: A 25-year-old white female, who had been receiving cabergoline 0.5 mg orally once per week for the preceding 2 months for a microprolactinoma, developed classic skin lesions of EN (proved ...
Matt R Soule +4 more
openaire +3 more sources
Cabergoline Resistance in Pediatric Prolactinomas
Journal of Pediatric Hematology/Oncology, 2009We report 3 cases of cabergoline resistance in adolescents with prolactinomas. All patients failed to respond to conventional doses of cabergoline. There are few reports on the management and outcome of dopamine agonist resistance in prolactinomas in the pediatric population, and our case series highlights the need for further research.
Joanne J. Spinks, Fiona J. Ryan
openaire +3 more sources